A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.

Author: BelliAnna-Maria, DanielsJane, LumsdenMary-Ann, ManyondaIsaac, McPhersonKlim, MiddletonLee, MossJon, WuOlivia

Paper Details 
Original Abstract of the Article :
Uterine fibroids are the most common tumour in women of reproductive age. By the time they are 50-years-old around 80% of women will have developed one. Of these, around half will experience symptoms which will impact negatively on their quality of life. Hysterectomy is the traditional treatment for...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258053/

データ提供:米国国立医学図書館(NLM)

FEMME Study: Choosing the Best Path for Women's Health

The field of women's health is constantly seeking innovative solutions for common conditions like uterine fibroids. This study examines the effectiveness of two minimally invasive treatments, myomectomy and uterine artery embolization (UAE), for women seeking to avoid hysterectomy. The researchers aim to determine which approach offers the best quality of life for these patients, emphasizing the need for patient-centered care in gynecological treatment. This study is a randomized controlled trial, known as the FEMME study, which is a robust research design that allows for a rigorous comparison of the two treatments.

Making Informed Choices in Women's Health

The FEMME study's findings hold significant value for women facing decisions about their health. By providing evidence-based insights into the effectiveness of myomectomy and UAE, it empowers women to make informed choices about their treatment, ultimately leading to improved quality of life.

Balancing Health and Well-being

Navigating the complexities of uterine fibroids can be a challenging experience for women. This study encourages an open and honest dialogue between patients and healthcare providers to explore the full range of treatment options available. Understanding the potential benefits and risks associated with each approach can empower women to make informed decisions that align with their personal values and health goals.

Dr.Camel's Conclusion

This research highlights the importance of personalized medicine in women's health. Like a desert oasis providing respite to weary travelers, innovative treatments like myomectomy and UAE offer women a path to improved health and well-being. By embracing a patient-centered approach, we can ensure that women have access to the most effective and personalized care, empowering them to navigate the challenges they face with confidence and strength.

Date :
  1. Date Completed 2015-08-06
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

25432688

DOI: Digital Object Identifier

PMC4258053

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.